PHYHD1-mediated translational control regulates renal cell carcinoma progression
Molecular Cell · 2026-11 · 86 (21) · 4481-4496.e9
DOI: 10.1016/j.molcel.2026.09.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2026-11. Verfasst von Qian Liang und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Protein Biosynthesis. Die Arbeit nennt 41 Literaturangaben. Gefördert von: NCI NIH HHS, Foundation for the National Institutes of Health, The Welch Foundation.
Abstract (Originalsprache)
The mechanisms underlying renal cell carcinoma (RCC) progression remain incompletely understood. Here, we identify phytanoyl-CoA dioxygenase domain containing 1 (PHYHD1) as a tumor suppressor that regulates translational homeostasis and RCC progression. Progressive PHYHD1 loss promotes tumor advancement and predicts poor prognosis, as revealed by integrative deep learning analysis of pan-cancer datasets. Restoring PHYHD1 suppresses tumor growth in RCC cell and patient-derived xenograft (PDX) models independently of its dioxygenase activity. Mechanistically, PHYHD1 interacts with translation elongation factor eEF1A1, alters its association with ribosomes, and restrains protein translation. Ribosome profiling and RNA-seq identify ceramide transporter 1 (CERT1) as a key effector of the PHYHD1-eEF1A1 axis. PHYHD1 depletion enhances CERT1 translation, whereas targeting CERT1 impairs proliferation of PHYHD1-deficient cells. These findings define a PHYHD1-eEF1A1-CERT1 axis that controls translation during RCC progression and highlight CERT1 as a potential therapeutic target in PHYHD1-deficient tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, Shanghai, China.
- Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Chemistry, The University of Hong Kong, Hong Kong, China.
Förderung
- NCI NIH HHS
- Foundation for the National Institutes of Health
- The Welch Foundation
- Cancer Prevention and Research Institute of Texas
Zitieren
APA
Liang, Q., Zurlo, G., Jin, J., Huang, D., Wei, Y., Shen, S., Liao, C., Wang, T., Zhang, C., Zhou, J., Liu, H., Fang, J., Fu, H., Takeda, M., Li, X., Li, X. D., Zhou, J., Wang, J., Yue, T., …, & Zhang, Q. (2026). PHYHD1-mediated translational control regulates renal cell carcinoma progression. Molecular Cell, 86(21), 4481-4496.e9. https://doi.org/10.1016/j.molcel.2026.09.020
Vancouver
Liang Q, Zurlo G, Jin J, Huang D, Wei Y, Shen S, et al. PHYHD1-mediated translational control regulates renal cell carcinoma progression. Molecular Cell. 2026;86(21):4481-4496.e9. doi:10.1016/j.molcel.2026.09.020
BibTeX
@article{Liang2026,
author = {Liang, Qian and Zurlo, Giada and Jin, Junru and Huang, Dengfeng and Wei, Yudong and Shen, Shuangjie and Liao, Chengheng and Wang, Tao and Zhang, Cheng and Zhou, Jin and Liu, Hongyi and Fang, Jun and Fu, Haoyong and Takeda, Masashi and Li, Xiang and Li, Xiang David and Zhou, Jian and Wang, Jinfan and Yue, Tao and Brugarolas, James and Buszczak, Michael and Zhang, Qing},
title = {PHYHD1-mediated translational control regulates renal cell carcinoma progression},
journal = {Molecular Cell},
year = {2026},
volume = {86},
number = {21},
pages = {4481--4496.e9},
doi = {10.1016/j.molcel.2026.09.020}
}
EUVIMED